Kohl Al-Ethmed in treatment of inflammation of the eyelid.
Phase 2
- Conditions
- Blepharitis.blepharoconjunctivitis
- Registration Number
- IRCT201208017219N4
- Lead Sponsor
- Vice chancellor for research, Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
anterior or posterior blepharitis in one or both eyes, recurrent chalazion.
Exclusion criteria: allergic blepharitis or conjunctival inflammatory disease, and the other anterior segment diseases of the eyes.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chalazion. Timepoint: Before Intervention , one month and two months after intervention. Method of measurement: Clinical examination with Slit lamp.;Blepharitis. Timepoint: before intervention, one month and two months after intervention. Method of measurement: Clinical examination with Slit Lamp.
- Secondary Outcome Measures
Name Time Method Eyelash loss. Timepoint: before intervention, one month and two months after intervention. Method of measurement: Clinical examination with Slit Lamp.;Keratitis. Timepoint: Before Intervention , one month and two months after intervention. Method of measurement: Clinical examination with Slit Lamp.